knowledge -WSS

knowledge

author：hotspot 2025-10-01 22:48:40 - browse：58

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Lilly’s weekly insulin works as well as daily products, new studies show

WSS

Novo Nordisk testing Wegovy against alcohol

Cigna wins case to block Amy Bricker's move to CVS

Cigna wins case to block Amy Bricker's move to CVS

Cherokee Nation medical school graduates its first class

The system is set up to fail children with medical complexity

New report analyzes digital physical therapy solutions' effectiveness

focus

knowledge

focus

The high cost of giving birth even with insurance

Teladoc has a new CEO, but challenges remain the same

Apple is now the first public company to be valued at $3 trillion

Cherokee Nation medical school graduates its first class

Medical leaders decry Supreme Court decision on affirmative action

New report analyzes digital physical therapy solutions' effectiveness

Cancer drug shortages should be causing more outrage

Free medical tuition alone isn't enough to close gaps in primary care

Novavax promises a turnaround & Lilly roils the obesity market

Hottest summer in 2,000 years puts focus on extreme heat, health

Wikipedia

WuXi Biologics execs register to lobby as Congress comes for the company

Obesity drug from Roche shows promise in early study

CVS is willing to dump 10% of its Medicare Advantage members

The United States must get value

Statins may not be needed by millions of people, study suggests

CVS is willing to dump 10% of its Medicare Advantage members

focus

explore

Wikipedia

explore